Gilder Gagnon Howe & Co’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
2022
Q1
$17.1M Sell
2021
Q4
$35.6M Buy
2021
Q3
$34.7M Sell
2021
Q2
$24.3M Sell
2021
Q1
$18M Buy
2020
Q4
$8.68M Sell
2020
Q3
$6.62M Sell
2020
Q2
$7.48M Buy
2020
Q1
$3.48M Buy
2017
Q4
Sell
2017
Q3
$2.79M Sell
2017
Q2
$1.93M Buy